PMID- 20551828
OWN - NLM
STAT- MEDLINE
DCOM- 20110602
LR  - 20151119
IS  - 1932-751X (Electronic)
IS  - 1932-7501 (Linking)
VI  - 30
IP  - 5
DP  - 2010 Sep-Oct
TI  - Written disclosure therapy for patients with chronic lung disease undergoing 
      pulmonary rehabilitation.
PG  - 340-5
LID - 10.1097/HCR.0b013e3181e174c4 [doi]
AB  - PURPOSE: Chronic lung diseases are typically associated with impaired quality of 
      life, stress, and anxiety. Written disclosure therapy (WDT) reduces stress in 
      patients with a variety of chronic illnesses. We sought to determine whether WDT 
      benefits patients with chronic lung disease. METHODS: A prospective, randomized, 
      controlled trial was performed to evaluate the effect of using WDT in patients (N 
      = 66) participating in a pulmonary rehabilitation program. Patients were randomly 
      assigned to write about a particularly traumatic life event (WDT group) or to 
      write about an emotionally neutral subject (control group). Exercise capacity, 
      dyspnea and quality of life, and values of spirometry were recorded at baseline, 
      at the end of the program, and at 6 months. RESULTS: The 6-minute walk distance 
      (6MWD) significantly improved in both groups at 2 months, from 278 to 327 m in 
      WDT and from 269 to 314 m in control groups (P < .01 in both groups). There was 
      no difference in improvement in 6MWD between groups (P = .88). At 6 months, the 
      gains made in 6MWD were no longer present. Dyspnea severity, as well as most of 
      the other domains of the Chronic Respiratory Disease Questionnaire and the St. 
      George's Respiratory Questionnaire, showed improvement within each group, but not 
      between WDT and control groups. CONCLUSION: WDT did not add any additional 
      benefit in patients with chronic obstructive pulmonary disease or idiopathic 
      pulmonary fibrosis when included as a component of pulmonary rehabilitation. 
      These results are in contrast to previously seen benefits in patients with 
      asthma.
FAU - Sharifabad, Manoochehr Abadian
AU  - Sharifabad MA
AD  - Winthrop University Hospital, Mineola, New York 11501, USA.
FAU - Hurewitz, Adam
AU  - Hurewitz A
FAU - Spiegler, Peter
AU  - Spiegler P
FAU - Bernstein, Mara
AU  - Bernstein M
FAU - Feuerman, Martin
AU  - Feuerman M
FAU - Smyth, Joshua M
AU  - Smyth JM
LA  - eng
PT  - Journal Article
PT  - Randomized Controlled Trial
PT  - Research Support, Non-U.S. Gov't
PL  - United States
TA  - J Cardiopulm Rehabil Prev
JT  - Journal of cardiopulmonary rehabilitation and prevention
JID - 101291247
SB  - IM
MH  - Adaptation, Psychological
MH  - Aged
MH  - Aged, 80 and over
MH  - Anxiety/psychology
MH  - Chronic Disease
MH  - Dyspnea
MH  - Exercise Test
MH  - Exercise Tolerance
MH  - Female
MH  - Forced Expiratory Volume
MH  - Humans
MH  - Male
MH  - Middle Aged
MH  - Prospective Studies
MH  - Pulmonary Disease, Chronic Obstructive/psychology/*rehabilitation
MH  - Pulmonary Fibrosis/psychology/*rehabilitation
MH  - Quality of Life/*psychology
MH  - Severity of Illness Index
MH  - Spirometry
MH  - *Stress, Psychological
MH  - Surveys and Questionnaires
MH  - Treatment Outcome
MH  - *Truth Disclosure
MH  - *Writing
EDAT- 2010/06/17 06:00
MHDA- 2011/06/03 06:00
CRDT- 2010/06/17 06:00
PHST- 2010/06/17 06:00 [entrez]
PHST- 2010/06/17 06:00 [pubmed]
PHST- 2011/06/03 06:00 [medline]
AID - 10.1097/HCR.0b013e3181e174c4 [doi]
PST - ppublish
SO  - J Cardiopulm Rehabil Prev. 2010 Sep-Oct;30(5):340-5. doi: 
      10.1097/HCR.0b013e3181e174c4.